欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1449/001
药品名称Addaven
活性成分
    • chromium(III)chloride hexahydrate 5.33 µg
    • Copper chloride dihydrate 0.1 mg
    • Ferric citrate hexahydrate 0.54 mg
    • Manganese chloride tetrahydrate 19.8 µg
    • Potassium iodide 16.6 µg
    • Sodium fluoride 0.21 mg
    • Sodium molybdate 4.85 µg
    • Sodium selenite hydrate 17.3 µg
    • Zinc chloride 1.05 mg
剂型Concentrate for solution for infusion
上市许可持有人Fresenius Kabi AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
    • Luxembourg (LU)
    • Austria (AT)
      Addaven Konzentrat zur Herstellung einer Infusionslösung
    • France (FR)
    • Poland (PL)
      Supliven
    • Hungary (HU)
      ADDAVEN koncentrátum oldatos infúzióhoz
    • Cyprus (CY)
      Addamel N New Concentrate for solution for infusion
许可日期2015/02/23
最近更新日期2025/08/11
药物ATC编码
    • B05XA31 electrolytes in combination with other drugs
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase